High feasibility of cytological specimens for detection of ROS1 fusion by reverse transcriptase PCR in Chinese patients with advanced non-small-cell lung cancer
Li Zhang(Zhejiang Sci-Tech University), Chun Zhou(Guangdong Pharmaceutical University), Tao Zhu(University of Science and Technology of China), Yaohe Wang(Queen Mary University of London), Xiangliang Liu(Jilin University), Sha Zhao, Chao Zhao(Tongji University), Tao Jiang(Tongji University), Shi Jiang, Li X, Jia Yin-ming
DOAJ (DOAJ: Directory of Open Access Journals)
May 1, 2019
Cited by 1
Related Papers
Investigating Novel Resistance Mechanisms to Third-Generation EGFR Tyrosine Kinase Inhibitor Osimertinib in Non–Small Cell Lung Cancer Patients
|Clinical Cancer Research|2018|551
Up-Regulation of TWIST in Prostate Cancer and Its Implication as a Therapeutic Target
|Cancer Research|2005|467
CXCR4 Regulates Interneuron Migration in the Developing Neocortex
|Journal of Neuroscience|2003|455
Camrelizumab Plus Carboplatin and Paclitaxel as First-Line Treatment for Advanced Squamous NSCLC (CameL-Sq): A Phase 3 Trial
|Journal of Thoracic Oncology|2021|311
Abnormal DNA methylation in CD4+ T cells from patients with systemic lupus erythematosus, systemic sclerosis, and dermatomyositis
|Scandinavian Journal of Rheumatology|2009|248